We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Teleflex
TFX
$5.98B
| $17.8M | 0.04% |
69,956
-13,826
| -17% | -$3.63M |
|
252
AdvanSix
ASIX
$444M
| $17.8M | 0.04% |
510,620
+6,629
| +1% | +$261K |
|
253
Cathay General Bancorp
CATY
$4.24B
| $17.7M | 0.04% |
441,776
-10,313
| -2% | -$441K |
|
|
VRTU
254
DELISTED
Virtusa Corporation
VRTU
| $17.6M | 0.04% |
+362,803
| New | +$17.3M |
|
|
FITB
255
Fifth Third Bancorp
FITB
$51.8B
| $17.6M | 0.04% |
552,767
-61,235
| -10% | -$2M |
|
256
First Financial Bancorp
FFBC
$3.53B
| $17.5M | 0.04% |
595,094
-24,872
| -4% | -$701K |
|
257
Raymond James Financial
RJF
$34B
| $17.4M | 0.04% |
291,254
-61,951
| -18% | -$3.85M |
|
258
Weyerhaeuser
WY
$18.4B
| $17.3M | 0.04% |
494,647
-79,001
| -14% | -$2.79M |
|
259
CVB Financial
CVBF
$3.99B
| $17.3M | 0.04% |
763,393
-27,147
| -3% | -$638K |
|
|
PPBI
260
DELISTED
Pacific Premier Bancorp
PPBI
| $17.2M | 0.04% |
428,712
-15,556
| -4% | -$648K |
|
|
BMTC
261
DELISTED
Bryn Mawr Bank Corp
BMTC
| $17.2M | 0.04% |
391,216
-25,968
| -6% | -$1.17M |
|
262
Texas Capital Bancshares
TCBI
$4.32B
| $17.2M | 0.04% |
191,022
-3,604
| -2% | -$338K |
|
|
AIMC
263
DELISTED
Altra Industrial Motion Corp
AIMC
| $17.1M | 0.04% |
373,170
+67,795
| +22% | +$3.25M |
|
|
IBKC
264
DELISTED
IBERIABANK Corp
IBKC
| $17M | 0.04% |
218,497
-16,739
| -7% | -$1.37M |
|
265
Artisan Partners
APAM
$3.02B
| $17M | 0.04% |
511,507
-16,329
| -3% | -$589K |
|
266
Wabtec
WAB
$49.3B
| $17M | 0.04% |
208,533
-19,342
| -8% | -$1.56M |
|
|
SRCI
267
DELISTED
SRC Energy Inc
SRCI
| $16.9M | 0.04% |
1,796,415
-68,237
| -4% | -$623K |
|
268
NovoCure
NVCR
$1.91B
| $16.8M | 0.04% |
+771,597
| New | +$16.6M |
|
269
CubeSmart
CUBE
$9.41B
| $16.8M | 0.04% |
596,108
-33,606
| -5% | -$916K |
|
|
ORBC
270
DELISTED
ORBCOMM, Inc.
ORBC
| $16.8M | 0.04% |
1,790,989
-59,729
| -3% | -$634K |
|
271
Bank OZK
OZK
$5.61B
| $16.7M | 0.04% |
345,759
-38,240
| -10% | -$1.93M |
|
272
Invesco QQQ Trust
QQQ
$481B
| $16.6M | 0.04% |
103,768
| – | – |
|
|
SLCA
273
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $16.6M | 0.04% |
649,264
-91,055
| -12% | -$2.79M |
|
274
AtriCure
ATRC
$2.11B
| $16.5M | 0.04% |
804,830
-24,365
| -3% | -$440K |
|
275
Teledyne Technologies
TDY
$32B
| $16.5M | 0.03% |
87,929
-17,579
| -17% | -$3.32M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.